Wayfinding Financial’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218K Sell
3,084
-45
-1% -$3.37K 0.09% 148
2025
Q4
$247K Sell
3,129
-345
-10% -$27.3K 0.1% 127
2025
Q3
$286K Buy
3,474
+38
+1% +$2.99K 0.12% 109
2025
Q2
$257K Sell
3,436
-333
-9% -$25.7K 0.11% 118
2025
Q1
$302K Buy
3,769
+309
+9% +$25.7K 0.13% 96
2024
Q4
$283K Buy
+3,460
New +$288K 0.15% 94
2024
Q3
Sell
-3,511
Closed -$246K 90
2024
Q2
$246K Sell
3,511
-177
-5% -$12.6K 0.14% 102
2024
Q1
$264K Sell
3,688
-77
-2% -$5.37K 0.15% 94
2023
Q4
$249K Buy
3,765
+193
+5% +$12.1K 0.17% 93
2023
Q3
$220K Buy
3,572
+83
+2% +$5.17K 0.17% 103
2023
Q2
$218K Buy
+3,489
New +$194K 0.15% 109

Other funds holding MET

Wayfinding Financial's MET Position: Q1 2026 in Review

Wayfinding Financial reduced its MetLife (MET) stake by 1.4% in Q1 2026, selling an estimated $3.37K and leaving 3,084 shares worth $218K. The position accounts for 0.09% of the portfolio, ranked #148.

Wayfinding Financial first reported a position in MET in Q2 2023 and has held it in 11 quarters since. The position peaked at $302K in Q1 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Wayfinding Financial held 3,084 shares of MetLife worth $218K as of Q1 2026.
  • Wayfinding Financial sold 45 MetLife shares in Q1 2026, an estimated $3.37K.
  • MetLife made up 0.09% of Wayfinding Financial's portfolio in Q1 2026, its #148 holding.
  • Wayfinding Financial first reported a position in MetLife in Q2 2023 and has held it in 11 quarters since.
  • Wayfinding Financial's MetLife position peaked at $302K in Q1 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Wayfinding Financial's 13F filing for Q1 2026, filed 12 May 2026.